Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / Fcpm Iii Services B.V.
Form 13F · Q2 2026

Fcpm Iii Services B.V.

CIK 2013410Filed 2026-08-1413F-HR View the filing on EDGAR ↗
$750M
Reported book value
15
Positions
11
Quarters on record
Top 50
Positions

Fcpm Iii Services B.V. — holdings

Top 11 positions of 15, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1NAMS Newamsterdam Pharma Company8.5M−7.7%$288M38.3%
2MPLT Maplight Therapeutics Inc3.2M+0.0%$116M15.4%
3DYN Dyne Therapeutics Inc3.8M−17.1%$85M11.4%
4VOR Vor Biopharma Inc4.1M+0.0%$76M10.1%
5DMRA Damora Therapeutics Inc2.4M+0.0%$63M8.5%
6REPL Replimune Group Inc2.8M+0.0%$31M4.1%
7CBIO Crescent Biopharma Inc.1.7M+0.0%$30M4.0%
8AURA Aura Biosciences Inc4.1M—$29M3.8%
9ENGENE HOLDINGS INC Engene Holdings Inc9.6M+0.0%$17M2.2%
10BCYC Bicycle Therapeutics Plc3.5M+0.0%$15M2.0%
11ENGENE HOLDINGS INC Engene Holdings Inc2.9M+0.0%$834,3760.1%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.